Dr. Johnsrud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16659 Southwest Fwy
Ste 131
Sugar Land, TX 77479Phone+1 281-276-5200Fax+1 281-276-5201
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2019
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2013 - 2016
- University of Texas Medical Branch School of MedicineClass of 2013
Certifications & Licensure
- TX State Medical License 2020 - 2025
- CA State Medical License 2019 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsDetection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.Sheren Younes, Shuchun Zhao, Sushma Bharadwaj, Alicia Palomino Mosquera, Diane Libert
Modern Pathology. 2023-10-01 - 36 citationsIncidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly
Blood Advances. 2021-11-09 - 12 citationsStem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafo...Andrew Johnsrud, Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein
Transplantation and Cellular Therapy. 2021-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: